KORONAVIRUS KASALLIK PATOGENEZI VA LABALATOR DIAGNOSTIKASI
Authors/Creators
- 1. Termiz iqtisodiyot va servis universiteti Tibbiyot fakulteti Davolash ishi yoʻnalishi 2-kurs 24-09 guruh talabalari
Description
Koronavirus kasalligi (COVID-19) – SARS-CoV-2 beta-koronavirusi tomonidan keltirib chiqariladigan o‘tkir nafas yo‘llari infeksiyasi bo‘lib, 2019-yildan boshlab global pandemiya ko‘rinishida millionlab odamlarni yuqtirgan va sog‘liqni saqlash tizimiga jiddiy yuklama solgan. Ushbu maqola SARS-CoV-2 virusining patogenezi va laborator diagnostikasining zamonaviy ilmiy ma’lumotlarini chuqur tahlil qilishga bag‘ishlangan. Patogenez bo‘limida virusning tuzilishi (to‘rt asosiy oqsil: spike (S), envelope (E), membrane (M) va nucleocapsid (N)), hujayraga kirish mexanizmi (ACE2 retseptori va TMPRSS2 proteaza orqali S1/S2 bo‘linishi), sitoplazmadagi replikatsiya jarayoni (RdRp fermenti ishtirokida), shuningdek, immun tizimning giperreaksiyasi – sitokin bo‘roni (IL-6, TNF-α, IL-1β va boshqa sitokinlarning haddan tashqari sekretsiyasi), endotelial disfunktsiya, mikrotrombozlar, o‘pka alveolalarida diffuz yallig‘lanish va ARDS (o‘tkir nafas yetishmovchiligi sindromi) rivojlanishi batafsil yoritiladi. Qo‘shimcha ravishda, virusning immun evaziyasi, variantlar (Omicron va boshqalar) ta’siri, to‘qimalarga bevosita zarar yetkazishi hamda uzoq muddatli asoratlar (long COVID) mexanizmlari ko‘rib chiqiladi.
Files
Xasanova M 374-382 ACU.pdf
Additional details
References
- . Nellore A, et al. IDSA 2025 Guidelines on the use of vaccines for the prevention of seasonal COVID-19, Influenza, and RSV infections in immunocompromised patients. Clinical Infectious Diseases. 2026 (advance online publication). doi:10.1093/cid/ciag114 10. Shumaker AH, et al. 2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Antiviral Treatment for Mild to Moderate COVID-19 in Adults. Clinical Infectious Diseases. 2025 (supplement).